NEW YORK (GenomeWeb News) – Co-Diagnostics and DNA Logix have created a joint venture to tackle infectious diseases in high-burden developing countries.

The venture, called Co-Diagnostics HBDC, will sell testing products and services based on PCR testing technology developed by DNA Logix to HBDCs. Co-Diagnostics HBDC is licensing the technology specifically for the HBDC market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.